How many expensive drugs can add tiny increments to efficacy and still be used/paid for?
Clearly all won't be big winners. But, with the size of the market, I'm a believer that there will be a few big winners in the Hep C space. Just stick to those companies reasonably priced. ; )
Market Data 
Markets 
AI
